| Literature DB >> 27044450 |
Derek T Holyoak1, Ye F Tian2, Marjolein C H van der Meulen3,4, Ankur Singh5.
Abstract
Osteoarthritis (OA) is a progressive, degenerative disease of articulating joints that not only affects the elderly, but also involves younger, more active individuals with prolonged participation in high physical-demand activities. Thus, effective therapies that are easy to adopt clinically are critical in limiting the societal burden associated with OA. This review is focused on intra-articular injectable regimens and provides a comprehensive look at existing in vivo models of OA that might be suitable for developing, testing, and finding a cure for OA by intra-articular injections. We first discuss the pathology, molecular mechanisms responsible for the initiation and progression of OA, and challenges associated with disease-specific targeting of OA. We proceed to discuss available animal models of OA and provide a detailed perspective on the use of mouse models in studies of experimental OA. We finally provide a closer look at intra-articular injectable treatments for OA, focusing on biomaterials-based nanoparticles, and provide a comprehensive overview of the various nanometer-size ranges studied.Entities:
Keywords: In vivo models; Interleukins; Intra-articular; Nanoparticles; Proteases
Mesh:
Year: 2016 PMID: 27044450 PMCID: PMC4880528 DOI: 10.1007/s10439-016-1600-z
Source DB: PubMed Journal: Ann Biomed Eng ISSN: 0090-6964 Impact factor: 3.934